Health Care/Hospital
Bee and Honey Promote Medical and Healthcare Products via Virtual Event
GUANGZHOU, China, April 25, 2022 /PRNewswire/ -- On 16 April, with the theme of "Fight against Pandemic, Care for Each Other", the second trade promotion activity of "Discover Canton Fair with Bee and Honey" was successfully held on Canton Fair's official Facebook account. The virtual event was h...
CanSinoBIO Rebrands to Reflect Commitment to Life Sciences Research
TIANJIN, China, April 25, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO" of "the Company") (SSE: , HKEX: 06185) today announced its new brand identity, which is intended to represent the Company's continuous dedication to life sciences research and its commitment to protecting the glo...
Novo Nordisk Indonesia takes a holistic approach to achieve zero environmental impact
JAKARTA, Indonesia, April 22, 2022 /PRNewswire/ -- In an attempt to achieve the company's ultimate goal to have zero environmental impact, Novo Nordisk Indonesia has initiated various activities, including switching the company's delivery method from air freight to sea freight and launching an in...
The 131st Canton Fair: Featured Creative Products for Health and Leisure
GUANGZHOU, China, April 22, 2022 /PRNewswire/ -- The 10-day 131st Canton Fair kicked off online onApril 15. The Health and Recreation section, among a wide range of exhibits, draws the attention of global buyers. Over 260,000 exhibits were displayed online by nearly 3,600 enterprises in the secti...
CStone Announces Results From Phase 3 AGILE Data of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine for Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia Published in the New England Journal of Medicine
* Results from the trial present a significant advancement for patients dealing with previously untreated IDH1-mutated AML * Global Phase 3 trial of TIBSOVO (ivosidenib tablets) met its primary endpoint of event-free survival and all key secondary endpoints, complete remission rate, overall s...
Lynk Pharmaceuticals Announces Clinical Approval in China for Its Class I New Drug LNK01004
HANGZHOU, China, April 22, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that its Class I innovative drug LNK01004, has been approved by National Medical Products Administration (NMPA) for c...
Telix Further Strengthens European Distribution Network for Illuccix
MELBOURNE, Australia and LIÈGE, Belgium, April 22, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces agreements with Sociedade Avanço, Unipessoal, LDA (Avanço) and THP Medical Products Vertriebs GmbH (THP) for the distribution of Telix's prostate ca...
Confusing health requirements are stopping passengers from flying
An international survey of people in the United States, the United Kingdom, Italy, and the Gulf reveals widespread confusion around health requirements for air travel, and fears that the aviation sector is not prepared for another global health crisis * Many people in every country surveyed sa...
Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets
* Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics * Transaction includes worldwide exclusive rights for development and commercialization in all fields of use NEW YORK, April 21, 2022 /PRNewswire/ -- Terran Biosciences, Inc. ("Terran"), a biotech platform company...
NTT DATA Begins Offering Vitals Measurement Service with a Smartphone Camera for Commercial Use in Partnership with Canadian Firm NuraLogix Corporation
TOKYO, April 21, 2022 /PRNewswire/ -- NTT DATA, a global digital business and IT services leader, today announced that it began providing a "Vitals Measurement Service" on a commercial basis fromJanuary 2022 as a new function of its cloud-based health management solution Health Data Bank®. This s...
Transcenta Successfully Passed the Audit of EU Qualified Person for the Manufacturing of TST001
SUZHOU, China, April 21, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that HJB (Hangzhou) ...
Nippon Express Obtains IATA CEIV Pharma Certification for Temperature-controlled Facility at Kansai International Airport
TOKYO, April, 21, 2022 /PRNewswire/ -- Nippon Express Co., Ltd. (hereinafter "Nippon Express"), a group company of Nippon Express Holdings, Inc., has obtained IATA CEIV Pharma (*) pharmaceutical transport quality certification, effectiveApril 5, for its temperature-controlled facility "NX-PHARMA ...
Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine
* Phase 1/2 clinical trial of COVID-19-Influenza combination vaccine candidate indicates vaccine is well-tolerated and immunogenic * Data from this combination trial will inform planned Phase 2 dose confirmation trial, scheduled to begin by the end of 2022 * Immune response confirmed in st...
REPROCELL Signs Agreement to Prospectively Collect Samples for IFF's Microbiome Study
BELTSVILLE, Md., April 20, 2022 /PRNewswire/ -- REPROCELL and IFF have entered into a clinical services agreement where in, REPROCELL will provide various types of samples for the study titled"Isolation and Characterization of Multiple Microbial Species from Diverse Healthy Adults (IsoMic)". The ...
ZEISS Announces U.S. FDA Clearance of the QUATERA 700, a Revolution in Phaco Technology
The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise. JENA, Germany and DUBLIN, Ireland, April 20, 2022 /PRNewswire/ -- Today, ZEISS Medical Technology announced the U.S. Food and Drug Administration (FDA) ...
JW Therapeutics Announces IND Approval for the Clinical Trial of Carteyva® in Pediatric and Young Adult Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
SHANGHAI, April 20, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, announced the Investigational New Drug (IND) clearance from the National Medical Products ...
Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on April 27 at 10:00 CEST
STOCKHOLM, April 20, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson. To register for the presentation o...
SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001
COPENHAGEN, Denmark, April 20, 2022 /PRNewswire/ -- SNIPR BIOME ApS, a leading CRISPR and microbiome gene therapy biotechnology company, today announced dosing of the first human subjects in its phase 1 clinical trial with SNIPR001, an orally administered CRISPR-based therapeutic. The purpose of...
Fit Hub Further Commits to Democratize Fitness for Everyone by Expanding its Branches Across 15 Cities in Indonesia
Fresh funding enables Fit Hub to advance with online-to-offline business plan to address challenges in lower tier cities inIndonesia. JAKARTA, Indonesia, April 20, 2022 /PRNewswire/ -- A technology-driven health and wellness company based inIndonesia, Fit Hub, is expanding its offline fitness c...
MILVIK BIMA RAISES FRESH INVESTMENT FOR DIGITAL HEALTH WALLET TECHNOLOGY
STOCKHOLM, LONDON and SINGAPORE, April 20, 2022 /PRNewswire/ -- MILVIK BIMA
("BIMA"), a leading digital healthcare solutions provider in emerging markets,
has raised new funds from existing shareholders Allianz X and Leapfrog
Investments to launch its Health Wallet inAsia.
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 302 media titles]
2024-04-15 17:33AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
[Picked up by 295 media titles]
2024-04-12 15:14LEGOLAND® School Challenge 2024 Expands Across Asia and Opens for Registration on April 15th
[Picked up by 276 media titles]
2024-04-11 11:00Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 275 media titles]
2024-04-15 08:00